Vitamin D and K2

The mechanism, in plain terms

Vitamin D's most established job is getting calcium into you. It increases how much calcium you absorb from the gut, which is why it matters so much for bone.

But absorption and destination are two separate questions, and this is the one almost nobody separates.

Calcium in your bloodstream can end up in bone, where you want it, or in soft tissue including artery walls, where you do not. Something has to direct it.

That is where vitamin K2 comes in. K2 activates a group of proteins by attaching a carboxyl group to them, and two of those proteins matter enormously here. Osteocalcin, which helps bind calcium into the bone matrix. And matrix Gla protein, which is one of the body's inhibitors of calcification in blood vessels.

Without adequate K2, those proteins remain in an uncarboxylated, inactive form. The calcium still arrives. The traffic direction is just weaker.

That is the whole logic behind pairing them, and it is a genuinely coherent mechanism rather than a marketing story.

What actually happens to people

The mechanism is elegant, and the question that matters is whether supplementing K2 changes anything measurable in people. That has now been tested directly.

A 2026 randomized placebo-controlled trial published in JAMA Cardiology, the VitaK-CAC study, enrolled 180 symptomatic patients with coronary artery calcification scores between 50 and 400 Agatston units across two hospitals in the Netherlands. They received 360 micrograms daily of menaquinone-7, the K2 form, or identical placebo, for two years, with CT scanning at one and two years.

In the placebo group, calcification scores rose from a median of 145 to 173 after the first year and 214 after the second. In the treatment group, from 135 to 150 to 184.

The difference between groups was significant at p equals 0.02, and it held after adjustment for covariates. No significant adverse effects were observed.

So: a real randomized trial, two years long, with a measured imaging outcome, showing slower calcification progression on K2.

Now the authors' own framing, which I want to pass on exactly rather than inflating. They wrote that the findings suggest MK-7 supplementation may slow calcification in noncalcified plaques, and that the clinical significance of this finding in terms of plaque stability remains to be determined.

That is the right level of confidence. A measured slowing of a surrogate marker, in a specific population with existing coronary disease, without yet knowing what it means for events. Genuinely encouraging, and not the same thing as proven cardiovascular protection.

The doses and durations that show up

The trial above used 360 micrograms of menaquinone-7 daily for two years, which tells you the shape of what was tested rather than what you personally should take.

K2 comes in forms, and MK-7 is the one used in most of the research, largely because it has a considerably longer half-life than MK-4 and therefore holds a steadier level on once-daily dosing.

Duration matters here more than with most pairings, because you are talking about the direction of calcium over years rather than an acute effect. The trial needed two years to show its difference, which is a fair indication of the timescale involved.

On the food side, K2 is found in fermented foods, notably natto, and in some cheeses and animal fats from pasture-raised animals. Vitamin K1 from leafy greens is a different form and does not substitute for K2 in this specific role, though your body converts a small amount.

The honest hedge

I am not a doctor and I am not diagnosing anyone, and there is one genuine safety line on this page that is not optional.

If you take warfarin, do not start vitamin K2 without your prescriber's involvement. Warfarin works by interfering with vitamin K, so changing your vitamin K intake changes how the drug behaves and can shift your INR. This is not a theoretical caution, it is the mechanism of the drug. A steady, known intake is what matters there, and that is a conversation with whoever manages your anticoagulation rather than a change to make quietly.

Beyond that, I want to keep the vitamin D side honest too. In 2024 the Endocrine Society published a communication stating it no longer endorses its previously proposed thresholds of sufficiency at or above 30 ng/mL, on the basis that trial evidence does not support specific thresholds predicting who benefits from supplementation in generally healthy people. That does not make vitamin D unimportant, and it does mean confident target numbers deserve less certainty than the last decade of advice implied.

So the sensible read on this pairing: the mechanism is well understood, the calcification trial is real and encouraging, and the outcome question is genuinely still open. That is a good reason to take K2 alongside D rather than a reason to expect a transformation.

So. What to actually do.

Tonight, at no cost. Read your vitamin D bottle and check whether it already contains K2. Many combined products exist, and people frequently take both separately without noticing they doubled one.

If you take warfarin, stop here and speak to your prescriber. That is the one hard line on this page.

Eat the food sources. Natto if you can stomach it, and otherwise some cheeses and pasture-raised animal fats. Leafy greens give you K1, which is valuable and is not the same thing.

Measure the D rather than guessing at it. A vitamin D test measures 25-hydroxy vitamin D, which is the right form for status, and it matters in both directions since D is fat soluble and accumulates.

Give it time before judging anything. The calcification trial needed two years. This is a slow-acting pairing by nature, so treat it as a long position rather than something to evaluate in a month.

Do not treat K2 as a substitute for the rest of cardiovascular care. Blood pressure, apoB, inflammation and blood sugar all belong in that picture, and no supplement replaces them.

None of this has to happen this week. But tonight you can read whether your D already contains K2.

You are not just absorbing calcium. You are directing it, and the direction matters at least as much as the amount that got in.

Your body is not broken. It is blocked. And sometimes the block is that you solved the absorption question years ago and nobody mentioned the traffic direction.

Go read your label.